For 2012, analysts are expecting 2.2% sales growth on EPS of $5.13, which is the middle of Johnson & Johnson's guidance.

Even if the company's results are at the top of its range, one has to wonder whether it will be enough to compel investors to buy the stock.

At the time of publication, the author held no positions in any of the stocks mentioned.

If you liked this article you might like

Crazy Weak U.S. Dollar Will Make These 10 Companies Huge Winners

Ridiculously Weak U.S. Dollar Will Make These 10 Companies Huge Winners

Johnson & Johnson Is Getting Ready for Another Upside Breakout

Shrug Off The Apple-FANG Bite: Cramer's 'Mad Money' Recap (Thur 9/14/17)